Praluent® (alirocumab) Injection Receives FDA Approval to
Approval extends treatment of Praluent to children aged 8 and older with heterozygous familial hypercholesterolemia (HeFH)...
Source: globenewswire.com
Page 7 - Nasdaq Regn News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nasdaq Regn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nasdaq Regn Today - Breaking & Trending Today
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Lifted by Braun Stacey Associates Inc.
Braun Stacey Associates Inc. lifted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.2% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 21,024 shares of the biopharmaceutical company’s stock after purchasing an additional 35 shares during the quarter. Braun Stacey […]
Source: dailypolitical.com
Connor Clark & Lunn Investment Management Ltd. Trims Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Connor Clark & Lunn Investment Management Ltd. reduced its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 84.3% during the 3rd quarter, HoldingsChannel reports. The firm owned 2,666 shares of the biopharmaceutical company’s stock after selling 14,287 shares during the quarter. Connor Clark & Lunn Investment Management Ltd.’s holdings in Regeneron […]
Source: wkrb13.com
Mather Group LLC. Buys 127 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Mather Group LLC. boosted its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 13.6% during the third quarter, HoldingsChannel reports. The fund owned 1,059 shares of the biopharmaceutical company’s stock after purchasing an additional 127 shares during the quarter. Mather Group LLC.’s holdings in Regeneron Pharmaceuticals were worth $872,000 at the […]
Source: dailypolitical.com
Oak Associates Ltd. OH Buys 35 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Oak Associates Ltd. OH lifted its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.4% in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 9,826 shares of the biopharmaceutical company’s stock after purchasing an additional 35 shares during the quarter. Oak Associates […]
Source: tickerreport.com